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Abstract
Background:  Individuals  with  attention-deﬁcit/hyperactivity  disorder  (ADHD)  are  reported  to
manifest visual  problems  (including  ophthalmological  and  color  perception,  particularly  for
blue--yellow  stimuli),  but  ﬁndings  are  inconsistent.  Accordingly,  this  study  investigated  visual
function and  color  perception  in  adolescents  with  ADHD  using  color  Visual  Evoked  Potentials
(cVEP), which  provides  an  objective  measure  of  color  perception.
Method:  Thirty-one  adolescents  (aged  13--18),  16  with  a  conﬁrmed  diagnosis  of  ADHD,  and  15
healthy peers,  matched  for  age,  gender,  and  IQ  participated  in  the  study.  All  underwent  an
ophthalmological  exam,  as  well  as  electrophysiological  testing  color  Visual  Evoked  Potentials
(cVEP), which  measured  the  latency  and  amplitude  of  the  neural  P1  response  to  chromatic
(blue--yellow,  red--green)  and  achromatic  stimuli.
Result:  No  intergroup  differences  were  found  in  the  ophthalmological  exam.  However,  sig-
niﬁcantly larger  P1  amplitude  was  found  for  blue  and  yellow  stimuli,  but  not  red/green  or
achromatic  stimuli,  in  the  ADHD  group  (particularly  in  the  medicated  group)  compared  to
controls.
Conclusion:  Larger  amplitude  in  the  P1  component  for  blue--yellow  in  the  ADHD  group  compared
to controls  may  account  for  the  lack  of  difference  in  color  perception  tasks.  We  speculate  that
the larger  amplitude  for  blue--yellow  stimuli  in  early  sensory  processing  (P1)  might  reﬂect  a
compensatory  strategy  for  underlying  problems  including  compromised  retinal  input  of  s-cones
due to  hypo-dopaminergic  tone.
© 2014  Spanish  General  Council  of  Optometry.  Published  by  Elsevier  España,  S.L.U.  All  rights
reserved.
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Visión  del  color  en  el  trastorno  de  déﬁcit  de  atención  e  hiperactividad:  un  estudio
piloto  de  potenciales  evocados  visuales
Resumen
Antecedentes:  Se  ha  reportado  que  las  personas  con  trastorno  de  déﬁcit  de  atención  e
hiperactividad  (TDAH)  maniﬁestan  problemas  visuales  (incluyendo  oftalmológicos  y  de  color,
particularmente  para  estímulos  azul-amarillo),  aunque  los  hallazgos  son  inconsistentes.  El  pre-
sente estudio  investigó  la  función  visual  y  la  percepción  del  color  en  adolescentes  con  TDAH,
utilizando  potenciales  evocados  visuales  (PEV),  que  aportan  una  medición  objetiva  de  la  per-
cepción del  color.
Métodos:  Participaron  en  el  estudio  treinta  y  un  adolescentes  (de  edades  comprendidas  entre
13 y  18  an˜os):  16  con  diagnóstico  conﬁrmado  de  TDAH  y  15  individuos  sanos,  equiparados  por
edad, sexo  e  IQ.  Todos  ellos  fueron  sometidos  a  examen  oftalmológico  y  a  pruebas  electroﬁsi-
ológicas de  PEV,  que  midieron  la  latencia  y  amplitud  de  la  respuesta  neuronal  P1  a  los  estímulos
cromáticos  (azul-amarillo,  rojo-verde)  y  acromáticos.
Resultados:  No  se  hallaron  diferencias  entre  los  grupos  en  el  examen  oftalmológico.  Sin
embargo, se  halló  una  amplitud  signiﬁcativamente  mayor  de  P1  para  los  estímulos  azul-amarillo,
aunque no  para  los  estímulos  rojo/verde  o  acromáticos,  en  el  grupo  de  TDAH  (particularmente
en el  grupo  medicado),  en  comparación  a  los  controles.
Conclusión:  La  mayor  amplitud  en  el  componente  P1  para  azul-amarillo  del  grupo  TDAH,  en
comparación  a  los  controles,  podría  explicar  la  falta  de  diferencia  en  las  tareas  de  percepción
del color.  Suponemos  que  la  mayor  amplitud  para  los  estímulos  azul-amarillo  en  el  proceso  senso-
rial temprano  (P1)  podría  reﬂejar  una  estrategia  compensatoria  para  los  problemas  subyacentes,
incluyendo  el  input  retiniano  comprometido  de  los  conos  S  debido  al  tono  hipo-dopaminérgico.
© 2014  Spanish  General  Council  of  Optometry.  Publicado  por  Elsevier  España,  S.L.U.  Todos  los
derechos reservados.
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Attention-deﬁcit/hyperactivity  disorder  (ADHD)  is  one  of
the  most  frequently  diagnosed  childhood  psychiatric  disor-
ders,  with  worldwide  prevalence  rates  estimated  at  5.3%.1
However,  despite  the  long  history  of  research  since  its
ﬁrst  medical  description  in  1775,2 to  date,  it  remains
unclear  what  are  the  ‘deﬁcits’  in  ADHD.  Current  theories
posit  that  executive  function  deﬁcits  account  for  ADHD
symptoms.  However,  according  to  a  substantial  number  of
studies,  ADHD  is  also  associated  with  visual  perceptual
problems  that  cannot  be  explained  by  executive  dysfunc-
tion  (appendix  A).  ADHD  is  a  neuro-developmental  disorder
which  is  associated  with  delayed  cortical  maturation  in
many  regions,  including  the  occipital  cortex.3,4 Speciﬁ-
cally,  color  perception  has  been  reported  to  be  altered
in  ADHD  population  (appendix  B).  For  instance,  in  our
previous  study,  young  adults  with  ADHD  reported  signiﬁ-
cantly  more  self-perceived  visual  difﬁculties  in  everyday
tasks  as  well  as  poorer  hue  discrimination  speciﬁcally  for
blue  stimuli.5 Furthermore,  children  with  ADHD  have  been
found  to  score  poorly  on  clinical  tests  of  blue--yellow  color
perception,  but  not  red--green,6,7 and  showed  decreased
game  performance  in  a  virtual  environment  when  impor-
tant  on-screen  information  was  displayed  predominantly  in
blue--yellow  colors  compared  to  performance  with  informa-
tion  displayed  in  red--green  colors.8 Finally,  several  studies
report  decreased  speed  in  color  processing  in  the  ADHD
population.9,10 The  possibility  of  color  perception  problems
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An  ADHD  is  of  clinical  importance,  given  the  extensive  use
f  color  in  educational  settings,  as  well  as  the  frequent  use
f  color  stimuli  in  many  of  the  standard  neuropsychological
ests  used  in  the  assessment  for  ADHD  and  related  disor-
ers  (e.g.  Color-Word  Stroop  Test,  Wisconsin  Card  Sorting
est,  A  Quick  Test  of  Cognitive  Speed,  Rapid  Automatized
aming).
Color  vision  mechanisms,  particularly  the  short-
avelength  pathway,  are  particularly  vulnerable  to  insult
rom  toxins,  and  highly  sensitive  to  CNS  drugs  and  the  neu-
otransmitter,  such  as  dopamine.  Accordingly,  the  ‘‘retinal
opaminergic’’  hypothesis  of  color  vision11 proposes  that
he  dopamine  deﬁciency  in  central  nervous  system  (CNS)
n  ADHD  population  may  induce  a hypo-dopaminergic  tone
n  the  retina,  which  in  turn  would  have  deleterious  effects
n  short-wavelength  (S)  cones.  S-cones  are  sensitive  to
lue--yellow  light  wavelengths  and  to  dopamine  (as  well
s  other  neurochemical  agents),  and  relatively  scarce  in
umber.  Thus,  the  purported  low  dopaminergic  tone  in
DHD  may  have  a  speciﬁc  effect  on  blue  color  perception.
o  our  knowledge,  so  far,  testing  this  hypothesis  in  the
DHD  population  has  solely  relied  on  clinical  tests  of
olor  perception.  Clinical  vision  tests  have  been  criti-
ized  for  their  requirements  for  sustained  attention  and
otor  coordination,  which  are  known  to  be  impaired  in
12,13DHD. Also  these  tests  do  not  inform  about  mechanisms
nderlying  poor  performance  on  B--Y  stimuli.  In  addition,
ost  of  these  studies  have  focused  on  children  with
DHD.5--7
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Measures18  
Accordingly,  this  pilot  study  is  aimed  to  explore  the  B--Y
olor  mechanism  in  an  extended  population  (adolescents
ith  ADHD)  using  an  electrophysiological  technique  (color
isual-evoked  potential;  cVEP).  cVEP  provides  a  noninva-
ive,  sensitive  and  objective  measure  of  chromatic  input
n  visual  pathways.14 Participants  are  directed  to  stare  at
he  stimuli  that  alternate  between  ‘on’  (100  ms)  and  ‘off’
400  ms)  while  brain  waves  are  measured  in  the  occipital
ortex.  cVEP  is  suitable  for  individuals  with  ADHD,  since  it  is
 purely  perceptual  task  in  which  the  stimuli  are  presented
ery  brieﬂy,  and  does  not  require  executive  function,  sus-
ained  or  selective  attention,  or  motoric  response.  To  our
nowledge,  no  previous  studies  examined  color  perception
rocessing  using  cVEP  in  ADHD  population.  However,  chil-
ren  with  learning  disability  have  been  reported  to  show  less
lpha  attenuation  using  parieto-occipital  EEGs,  suggesting
hat  attention  problems  may  inﬂuence  learning  disability.15
oor  readers  have  also  been  found  to  manifest  signiﬁ-
antly  lower  thresholds/higher  sensitivity  for  B--Y  stimuli
han  normal  readers.16 By  contrast,  based  on  visual  pat-
ern  electroretinograms,  adults  with  ADHD  were  not  found
o  show  a  signiﬁcantly  larger  contrast  gain  than  control
roup,17 nor  were  any  latency  differences  (N75,  P100,  N145)
ound  for  children  with  ADHD  using  pattern  reversal  evoked
otential.18
In  this  study,  we  measured  the  neural  response  (P1)  to
hromatic  and  achromatic  stimuli,  thereby  providing  a  more
irect  assay  of  color  processing  in  this  population.  The  P1
omponent  of  the  cVEP  (peak  latency  136--146  ms)  is  an  early
esponse  to  the  visual  stimuli  and  it  is  mainly  generated
rom  the  dorsal  extrastriate  cortex  where  color  processing
s  localized.19--22 In  addition,  we  conducted  an  ophthalmo-
ogical  exam  (e.g.,  visual  acuity,  refraction,  fundus  exam)
o  test  general  visual  functions  in  ADHD.  We  hypothesized
hat  the  adolescents  with  ADHD  would  show  normal  visual
unction  on  ophthalmological  exam,  but  altered  B--Y  color
ision  as  indexed  by  both  latency  and  amplitude  of  P1.
peciﬁcally,  we  expected  ADHD  group  to  show  deﬁcient  neu-
al  activity  in  response  to  B--Y  stimuli  shown  as  decreased
mplitude  and  prolonged  latency  of  P1  compared  to  control
roup.
ethods
articipants
 total  of  31  adolescents,  aged  13--18  years,  participated;
6  (81%  male,  mean  age:  16)  with  a  conﬁrmed  DSM-IV39
iagnosis  of  ADHD  (described  below)  and  15  (67%  male,
ean  age:  15)  healthy  controls  matched  for  age,  sex,  and
Q.  No  signiﬁcant  differences  were  found  in  age  and  sex
etween  the  groups.  Adolescents  with  conﬁrmed  ADHD  diag-
osis  were  recruited  from  a  larger-scale  study  on  working
emory  (Canadian  Institutes  of  Health  Research  operat-
ng  grant  #  11398);  those  in  the  comparison  group  were
ecruited  through  notices  posted  in  the  research  setting
a  large  pediatric  hospital  in  an  urban  area).  All  ado-
escents  participating  in  the  study  were  native  English
peakers.  Adolescents  were  excluded  if  mothers  reported
 history  of  major  perinatal  complications  such  as  prema-
urity,  low  birth  weight,  any  history  or  current  presentation
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f  psychosis,  comorbid  Tourette  syndrome,  phenylketonuria,
utism,  or  other  pervasive  developmental  disorders.  Also
dolescents  were  excluded  if  they  had  a history  or  current
se  of  cocaine  or  other  substances,  or  had  below  aver-
ge  intellectual  functioning  (deﬁned  as  a  standard  score
f  at  least  80  on  either  the  Verbal  or  Performance  Scale
f  the  WISC-III).  We  chose  to  study  adolescents,  because
hey  would  be  able  to  understand  and  comply  with  the  cVEP
equirements.
The  DSM-IV  diagnosis  of  ADHD  had  been  conﬁrmed  by
 systematic  and  comprehensive  clinical  diagnostic  assess-
ent  conducted  within  the  past  one  to  2  years,  as  a
art  of  the  larger  scale  study.  Assessment  consisted  of
 semi-structured  clinical  diagnostic  interview  [Schedule
or  Affective  Disorders  and  Schizophrenia  for  School-Age
hildren-Present  and  Lifetime  Version;  K-SADS-PL23],  as
ell  as  the  Conners’  Rating  Scales-Revised,24 completed
y  parents  and  teachers.  The  K-SADS  had  been  conducted
eparately  with  the  adolescent  and  parent,  and  the  clin-
cian  summarized  the  information  from  both  informants.
iagnosis  of  ADHD  in  adolescents  had  been  based  on  the
ollowing  algorithm:  (1)  met  DSM-IV  criteria  according
o  the  clinician  summary  based  on  the  K-SADS-PL  inter-
iews;  and  (2)  met  the  clinical  cut-offs  for  inattentive  or
yperactive/impulsive  symptoms  on  the  Conners’  teacher
uestionnaires  (t-score  >  70)  to  conﬁrm  pervasiveness  of
ymptoms  across  settings.
For  the  current  study,  parents  of  all  participants  were
sked  to  complete  the  Strengths  and  Weaknesses  of  ADHD-
ymptoms  and  Normal  Behavior  Scale  (SWAN25),  using  a
-point  likert  scale  for  each  item  (score  of  ‘1’  indicating
he  child’s  abilities  were  far  below  those  of  peers;  score  of
7’  indicating  abilities  far  above  those  of  peers)  to  index
urrent  symptomatology.  Total  scores  for  inattention  and
yperactivity/impulsivity  were  computed,  with  lower  scores
ndicating  more  problems.  Also,  parents  as  well  as  tea-
hers  completed  the  Strengths  and  Difﬁculties  Questionnaire
SDQ26) to  obtain  standardized  ratings  of  current  behavior.
dolescents  in  the  comparison  group  who  had  any  scores
n  the  clinical  range  were  excluded.  Informed  consent  from
he  participating  adolescents  and  their  parents  was  obtained
efore  the  test.
Participants  with  ADHD  who  were  being  treated  with
timulant  medication  (n  =  7;  35%  of  the  sample)  were
equested  to  stop  any  stimulant  medication  for  at  least
4  h  prior  to  the  study.  However,  since  we  had  no  reliable
ethod  for  conﬁrming  that  participants  had  indeed  ceased
heir  treatment  for  more  than  24  h,  we  opted  to  classify  par-
icipants  with  ADHD  into  two  groups:  those  with  and  without
urrent  medication  treatment.
This  study  was  approved  by  our  institutional  Research
thics  Board  (The  Hospital  for  Sick  Children:  REB  ﬁle
1000003973);  all  participants  (adolescents,  parents)  pro-
ided  written  informed  consent  prior  to  commencing  the
tudy.phthalmological  exam: a  comprehensive  vision  exam,  con-
ucted  under  speciﬁed  lighting  conditions  by  a  trained
phthalmologist,  included  the  following  measures:
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to  peak.  The  artifact  reject  was  set  to  ±  100  V,  thus,  arti-
facts  from  non-visual  sources  such  as  muscle  artifact  (i.e.
eye  blink)  would  be  eliminated.
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Figure  1  A  color  VEP  data  of  a  participant  from  blue--yellow
(S-cone  onset)  stimuli.  Latency  (time  of  response  to  stimulus)
for S  response  onset  is  measured  from  pattern  onset  (time  ofColor  Vision  in  ADHD-  A  pilot  VEP  study  
-  Contrast  sensitivity27:  Contrast  sensitivity  was  measured
by  the  Pelli-Robson  Contrast  Sensitivity  Test,  which  pro-
vides  a  quick,  reliable  and  widely  accepted  method  used
in  clinical  setting.  Higher  scores  indicate  better  contrast
sensitivity  (i.e.  can  discriminate  fainter  letters  better  on
a  white  chart).  The  highest  possible  score  is  2.25.
-  Visual  acuity  (Vistech  Consultants,  Inc.  Dayton,  USA):  It
was  measured  with  the  log  MAR  crowded  test.  Lower
scores  indicate  better  visual  acuity/resolution.  Lowest
score  is  −0.3.
-  Refraction28:  It  was  measured  using  a  near  retinoscopy
technique.  Spherical  correction  and  cylindrical  cor-
rection  are  reported  for  left,  right,  and  both  eyes.
Since  uncorrected  refractive  error  might  confound  the
results,  adolescents  with  uncorrected  refractive  error
greater  than  3.00  diopters  spherical  correction  or  1.50
diopters  cylindrical  correction  were  excluded  from  the
study.
-  Fundus  exam: A  basic  fundus  examination  was  carried  out
with  the  ophthalmoscope  to  determine  the  ocular  media,
posterior  pole  and  macular  area  of  the  retina.
Color  Visual  Evoked  Potentials  (cVEP;  NeuroScan  Acquire
4.0  program):  cVEP  is  an  objective,  non-invasive  technique
that  particularly  reﬂects  cone  activity  in  the  central  6--10
degrees  in  the  retina.29 It  permits  recording  of  an  occipital
lobe  brain  wave  in  response  to  visual  stimulation  that  begins
in  the  retina  and  ends  at  the  visual  cortex.30 In  the  current
study,  three  types  of  stimuli  were  used.  The  ﬁrst,  the  achro-
matic  grating  was  a  white-gray  luminance  stimulus  to  verify
that  meaningful  VEP  signals  could  be  collected.  The  second
was  an  isoluminant  grating  for  long  and  medium  wavelength
color  mechanisms  (red--green).  The  third  type  was  an  isolu-
minant  S-grating  speciﬁc  for  S-cone  activation-deactivation
(blue--yellow).  Achromatic  and  chromatic  stimuli  were  pre-
sented  in  a  patterned  onset-offset  presentation.  This  means
that  the  stimulus  alternated  between  ‘‘on’’  (for  100  ms)  and
‘‘off’’  (for  400  ms)  at  a  repeated  rate  of  2  Hz,  until  60  sweeps
were  collected.  The  time  of  luminance  presentation  con-
sistently  occurred  between  chromatic  stimuli  so  as  not  to
saturate  the  color  vision  system.
Stimulus  parameters  were  selected  to  optimize  the  chro-
matic  response  and  differentiate  between  the  chromatic
and  achromatic  VEP  response  (see  Elia  et  al.31 for  the
details).  Chromatic  and  achromatic  stimuli  were  produced
using  Vision  Research  Graphics  (VRG)  software  (Durhan,
NH).  Speciﬁcally,  the  red--green  color  grating  consisted  of
vertical  bars  varying  from  red  to  green  with  respective  chro-
maticity  coordinates  of  x  =  0.3574,  y  =  0.3099  and  x  =  0.3064,
y  =  0.3372.  The  violet  to  yellow--green  grating  consisted  of
alternating  violet  (x  =  0.2893,  y  =  0.2496)  and  yellow--green
(x  =  0.3409,  y  =  0.3523)  bars.  Each  of  the  color  stimuli  pairs:
red  and  green  or  blue  or  yellow  were  isoluminant.  This  was
to  ensure  that  the  cortical  responses  being  recorded  arose
predominantly  from  color  selective  cortical  cells  and  not
from  luminance-responsive  cells.32 These  stimuli  were  pre-
sented  on  a  21-inch  RGB  color  graphics  monitor  (FlexScan
f930;  Eizo,  Cypress,  CA)  with  26◦ ×  20◦ ﬁeld  dimensions.  Pre-
vious  research  has  demonstrated  good  test--retest  reliability
using  this  large  stimulus  display  with  the  NeuroScan  Aquire
4.0  Program.33
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We  positioned  6-mm  diameter  gold  disk  electrodes  (Gen-
ine  F-F5GH;  Grass  Instrument  Division,  Astro-Med,  Inc.,
est  Warwick,  RI)  with  protected  terminals  (Safelead;
rass)  on  the  scalp,  as  stated  in  the  international  10--20
ystem  of  electrode  placement,  on  the  visual  occipital
ortex  in  positions  Oz,  O1,  and  O2  along  with  two  addi-
ional  electrodes  on  nonvisual  areas  of  the  cortex  at  Pz
ground)  and  Cz  (reference),  to  obtain  cortical  responses
o  color  stimuli.  The  Scalp-electrode  impedance  was  mea-
ured  after  all  electrodes  are  applied  to  ensure  that  the
mpedance  was  less  than  or  equal  to  10  k.  Color  VEPs  were
ecorded  at  a  viewing  distance  of  75  cm.  Each  participant
as  tested  binocularly.  A  ﬁxation  target  (central  dot)  was
resented  to  maintain  participants’  visual  attention.  Also,
 tester,  who  was  positioned  behind  the  computer,  moni-
ored  participant’s  eye  gaze  and  was  responsible  for  starting
nd  stopping  the  trial  if  the  participant  became  tired  and
ost  ﬁxation  on  the  stimulus.  The  trial  was  restarted  once
he  participant  had  re-established  his/her  gaze  on  the
timulus.
For  VEP  data  analysis,  waveforms  were  recorded  for
chromatic,  L-M  and  S  patterns.  Sixty  presentations  were
cquired  and  averaged  for  each  stimulus,  which  was  pre-
ented  twice.  Thus,  a  total  of  120  presentations  per  each
ondition  were  recorded.  We  measured  both  VEP  latency
s  well  as  amplitude.  Since  latency  of  VEP  waveform  gener-
ted  by  chromatic  stimuli  (both  red--green  and  blue--yellow)
s  typically  negative  wave,  in  adults,34 the  latency  of  chro-
atic  onset-offset  VEP  data  was  measured  from  pattern
nset  to  the  ﬁrst  negative  component.  Peak  amplitudes  were
easured  from  the  trough  of  the  ﬁrst  negative  wave  to  the
eak  of  the  preceding  positive  wave  for  wave  generated  by
hromatic  stimuli  (Fig.  1  shows  an  example  for  a  male  par-
icipant  in  this  study).  The  VEP  system  (NeuroScan  Acquire
.0  program)  acquired  averaged  VEP  data  from  the  Synamps
mpliﬁer  system  (NeuroScan,  Herdon,  Virginia).  The  samp-
ing  frequency  was  1000  Hz.  The  noise  level  was  2  V  peaktimulus  presentation)  to  the  trough  of  the  ﬁrst  large  negative
ave. Amplitudes  of  the  waveforms  were  measured  from  the
rough  of  the  ﬁrst  negative  wave  to  the  peak  of  the  positive
ave.
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nalysis
ata  points  (behavioral  and  ERP)  with  SD’s  >3  were  regarded
s  outliers  and  adjusted  using  a  winsorizing  technique.35 This
as  applied  to  a total  of  seven  data  points:  one  data  point
rom  Left  Acuity,  Left  contrast  sensitivity,  right  spherical
orrection,  Left  cylindrical  correction,  Right  cylindrical  cor-
ection,  and  2  data  points  from  red--green  latency.  Also,  3
ontrol  participants  were  excluded  from  VEP  tests  due  to
eak  VEP  signals  and  very  low  motivations  (observed  tired-
ess,  boredom  and  lack  of  sleep).  We  used  both  relatives
difference  in  luminance  to  chromatic  data)  to  control  for
nter-individual  variability  and  also  absolute  values  to  ana-
yze  amplitude  and  latency.  Planned  orthogonal  contrast
nalyses  were  used  to  test  the  hypothesized  group  differ-
nces  in  color  perception  and  other  visual  functions.  We
rst  compared  the  ADHD  and  control  groups,  and  then  the
edicated  versus  non-medicated  ADHD  subgroups.  Effect
izes  (ES)  were  calculated  using  Cohen’s  d.36 Convention-
lly,  Cohen’s  d  ranging  0.2--.03  is  considered  to  be  a  small
ffect  size,  0.5  as  medium  and  0.8  as  large,  respectively.  No
onferroni  correction  for  multiple  comparisons  was  applied
ince  this  was  a  pilot  study  and  not  adequately  powered  for
epeated  measures  ANOVA.
esults
ample  characteristics  and  performance  on  vision  meas-
res  are  summarized  in  Tables  1  and  2, respectively.
s  expected,  adolescents  with  ADHD  showed  signiﬁcantly
ore  inattentive  [t(27)  =  −6.627,  p  =  0.000]  and  hyperac-
ivity  symptoms  [t(27)  =  −2.990,  p  =  0.006]  than  control
dolescents  based  on  parent’s  report  on  SWAN.  Further-
ore,  the  medicated  ADHD  subgroup  tended  to  show  more
nattentive  symptoms  than  non-medicated  ADHD  subgroup,
trend  level  difference),  suggesting  that  medicated  sub-
roup  may  present  more  severe  ADHD  symptoms  (Table  1).
lso,  ADHD  group  showed  signiﬁcantly  more  overall  difﬁcul-
ies  in  school  [t(27)  =  −4.233,  p  =  0.000]  as  well  as  in  home
ettings  [t(27)  =  3.304,  p  =  0.003].
There  were  no  group  differences  in  general  vision  based
n  the  ophthalmological  tests  including  visual  acuity,  con-
rast  sensitivity,  and  refraction.  Clinical  notes  on  the  fundus
xam  suggested  that  the  fundus  was  within  normal  limits  for
irtually  all  participants  except  1  participant  in  each  ADHD
nd  Control  group  (see  appendix  C  for  detail).
On  VEP  measures,  using  relative  values, no  signiﬁcant
roup  differences  were  found  for  the  P1  latency,  but  the
DHD  group  (both  medicated  and  non-medicated  partici-
ants)  showed  signiﬁcantly  larger  P1  amplitude  in  response
o  blue--yellow  stimuli  than  did  the  comparison  group
t(25)  =  2.35,  p  <  0.05;  Cohen’s  d  = 0.80,  see  Fig.  2],  but  the
roups  did  not  differ  in  either  latency  or  amplitude  in
erms  of  the  P1  response  to  red--green  stimuli  [t  (24)  =  0.183,
 = 0.86;  Cohen’s  d  =  0.11].  The  group  differences  in  P1
mplitude  in  response  to  blue--yellow  stimuli  appear  to  be
riven  primarily  by  the  ‘medicated’  ADHD  group,  since  their
1  amplitude  was  signiﬁcantly  larger  compared  to  that  of
he  non-medicated  subgroup  [t(25)  =  2.18,  p  <  0.05;  Cohen’s
 = 0.77].  Similarly,  using  absolute  values, the  ‘medicated’
DHD  group  showed  signiﬁcantly  larger  P1  amplitude  for
Color
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Table  2  Summary  scores  on  vision  Table  1.
Measures  Descriptives  Planned  orthogonal  contrast  analysis
Med.  ADHD  (N  =  7) Non  Med.  ADHD  (N  =  9) ADHD  (N  =  16) Controls  (N  =  12) ADHD  (N  =  16)  vs.
Control  (N  =  12)
Med.  ADHD  (N  =  7)  Vs.
Non  Med.  (N  =  8)
Mean  SD  Mean  SD  Mean  SD  Mean  SD  Mean  difference Mean  difference
Vision
Contrast  sensitivity(R) 1.69 0.08 1.65 0.09 1.67 0.09 1.64 0.06 0.03 0.04
Contrast  sensitivity(L) 1.70 0.10 1.66 0.09 1.68 0.09 1.66 0.07 0.03 0.04
Contrast  sensitivity(Bi) 1.85 0.10 1.79 0.11 1.82 0.10 1.81 0.09 0.01 0.06
Visual  Acuity  (R) −0.11 0.10 −0.08 0.16 −0.09 0.13 −0.04 0.15 −0.05 −0.03
Visual  Acuity  (L) −0.09 0.10 −.12 0.09 −0.11 0.09 −0.09 0.08 −0.02 −0.03
Visual  Acuity  (Bi) −0.16 0.05 −0.18 0.08 0.07 0.02 −0.15 0.08 −0.02 0.02
Spherical  correction  (R) −0.38 1.05 −0.09 0.94 −0.21 0.96 −0.16 1.32 0.05 −0.29
Cylindrical  correction  (R) 0.08 0.20 0.03 0.28 0.05 0.24 −0.07 1.04 −0.02 0.05
Spherical  correction  (L) −0.25 0.88 −0.19 1.67 −0.21 1.34 −0.01 1.60 −0.21 −0.06
Cylindrical  correction  (L) 0.17 0.26 0.09 0.19 0.13 0.21 0.17 0.41 −0.04 0.08
Color  vision
Red  Tritan  (L)  1.00  0.00  1.11  0.33  1.06  0.25  1.00  0.00  0.06  −0.11
Green Tritan  (L)  1.00  0.00  1.00  0.00  1.00  0.00  1.07  0.26  −0.07  0.00
Blue Tritan  (L)  1.00  0.00  1.11  0.33  1.06  0.25  1.07  0.26  −0.01  −0.11
Red Tritan  (R)  1.14  0.38  1.00  0.00  1.06  0.25  1.13  0.35  −0.05  0.14
Green Tritan  (R)  1.00  0.00  1.00  0.00  1.00  0.00  1.00  0.00  0.00  0.00
Blue Tritan  (R)  1.29  0.49  1.22  0.44  1.25  0.45  1.13  0.35  0.12  0.07
VEP
Relative
Blue--Yellow latency(ms)  145.54  4.66  149.56  10.20  147.80  8.27  152.42  9.22  −4.62  −4.02
Red--Green latency  (ms)  140.55  9.08  143.13  6.17  142.00  7.42  141.36  6.30  0.64  −2.58
Blue--Yellow amplitude(V)  1.78  0.35  1.44  0.24  1.59  0.33  1.34  0.32  0.25* 0.34*
Red--Green  amplitude  (V)  1.70  0.45  1.88  0.43  1.81  0.43  1.76  0.49  0.05  −0.18
Absolute
Blue--Yellow latency  (ms)  148.21  7.72  147.26  8.97  147.74  8.35  148.68  10.17  −0.94  −0.95
Red--Green latency  (ms)  139.76  8.13  139.19  7.41  139.48  7.77  140.15  7.64  −0.96  −0.57
Luminance latency  (ms)  149.87  10.87  144.77  12.69  147.32  11.78  147.81  10.14  −0.49  −5.11
Blue--Yellow amplitude(V)  7.81  5.02  3.62  3.02  5.72  5.37  6.32  5.94  −0.60  2.12*
Red--Green  amplitude  (V)  9.96  6.32  6.78  7.03  8.37  6.67  10.53  8.41  −2.16  3.18
Luminance amplitude  (V)  10.89  5.85  9.95  5.93  10.42  5.89  13.33  8.20  −2.91  −0.94
(1) R: Right eye only, (2) L: Left eye only, (3) Bi: Binocular vision.
* P < 0.05.
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chromatic  stimuli  compared  to  that  for  red--green  stimuli
(e.g.,  Cohen’s  d  for  B--Y  was  0.80;  and  for  R--G  was  0.11).
This  ﬁnding  is  in  line  with  a previous  ﬁnding  that  found
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GroupFigure  2  Relative  amplitude  (V)  of  the  VEP  response  to
lue  and  yellow  stimuli  compared  to  the  non-medicated
DHD  group  [t  (46)  =  4.19,  p  <  0.05;  Cohen’s  d  =  1.01],  but
id  not  differ  in  latency  [t(46)  =  −0.267,  p  =  0.791; Cohen’s
 =  0.11].  However,  the  ADHD  group  overall  did  not  differ
rom  controls  in  either  amplitude  or  latency  of  response
o  blue--yellow  and  red--green  stimuli  (see  Table  2).  More-
ver,  the  ADHD  subgroups  did  not  differ  in  either  latency
t(46)  =  −0.189,  p  =  0.765;  Cohen’s  d  =  0.08]  or  amplitude
t(46)  =  1.09,  p  =  0.28;  Cohen’s  d  =  0.47]  in  terms  of  the  P1
esponse  to  red--green  stimuli.
Additional  analysis  was  conducted  using  achromatic
timuli  (luminance),  although  these  stimuli  were  used  pri-
arily  as  an  experimental  control  condition  designed  to
revent  saturation  of  the  color  vision  system.  No  signiﬁcant
ntergroup  differences  were  found  in  amplitude  or  latency
or  achromatic  stimuli  (see  Table  2).
Inattentive  symptoms  from  parent  ratings  on  the  SWAN
orrelated  signiﬁcantly  with  P1  amplitude  in  response  to  B--Y
timuli  [r(27)  =  −0.386,  p  =  0.046]  but  not  for  R--G  stimuli
r(27)  =  −0.195,  p  =  0.330],  indicating  that  more  severe  inat-
ention  was  related  to  greater  P1  amplitude  for  B--Y  (see
catter  plot  in  Fig.  3).  By  contrast,  there  was  no  signiﬁcant
elationship  between  hyperactivity/impulsivity  scores  and
he  P1  amplitude  for  either  B--Y  [r(27)  =  −0.286,  p  =  0.146  or
--G  stimuli  [r(27)  =  −0.132,  p  =  0.495].
iscussion
his  study  represents  the  ﬁrst  attempt  to  use  cVEP  to  assay
olor  perception  in  an  ADHD  sample.  Moreover,  we  con-
ucted  ophthalmological  testing  to  allow  us  to  disaggregate
olor  perception  problems  from  problems  in  vision.  The
ajor  ﬁndings  in  this  pilot  study  were  that:  (1)  the  ADHD
roup  (particularly  the  ‘medicated’  group)  showed  a  much
arger  P1  amplitude  in  response  to  blue--yellow  stimuli  than
id  the  comparison  group,  but  did  not  differ  in  terms  of  the
1  latency;  (2)  there  were  no  intergroup  differences  in  the
1  amplitude  or  latency  in  response  to  red--green  or  achro-
atic  stimuli;  (3)  inattention  signiﬁcantly  correlated  with
he  P1  amplitude,  only  for  B--Y  stimuli;  and  (4)  there  was  no
F
amatic  onset  stimuli  (left  =  blue--yellow,  right  =  red--green).
vidence  in  ophthalmological  problems  in  the  ADHD  group
ased  on  the  clinical  measures.
The  present  study  yielded  several  novel  ﬁndings,  includ-
ng  evidence  of  greater  amplitude  in  the  P1  component
f  the  neural  response  to  B--Y  chromatic  stimuli  in  the
DHD  group,  together  with  a  signiﬁcant  positive  relation-
hip  between  severity  of  inattention  symptoms  and  the  P1
mplitude  for  B--Y  stimuli.  The  magnitude  of  this  group  dif-
erence  in  P1  amplitude  was  notably  larger  for  blue--yellowClinical_Medicated Clinical_Not medicated
Control
igure  3  Scatter  plot  between  Inattentive  symptom  on  SWAN
nd relative  P1  amplitude  (V)  on  blue--yellow.
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hypersensitivity  for  the  blue/yellow  stimuli  in  children  with
reading  disabilities.16 Although  the  intergroup  difference
in  the  P1  amplitude  for  B--Y  stimuli  appears  to  be  driven
primarily  by  the  adolescents  with  ADHD  who  were  being
treated  with  stimulant  medication,  there  are  several  rea-
sons  why  we  do  not  believe  that  this  intergroup  difference
can  be  attributed  to  the  effects  of  stimulant  medication
per  se.  First,  P1  amplitude  correlated  positively  with  the
SWAN  inattention  scores  (see  Fig.  3)  and  the  medicated
ADHD  subgroup  showed  higher  SWAN  inattention  scores
than  the  non-medicated  ADHD  group  albeit  non-signiﬁcantly
(see  Table  1),  which  may  suggest  that  medicated  ADHD
group  manifest  more  severe  ADHD  symptoms  that  required
treatment  with  medication.  Second,  participants  in  the
‘medicated’  group  had  been  asked  to  stop  their  medication
for  at  least  24  h  before  the  test  session  and  indicated  that
they  had  done  so,  although  we  were  unable  to  conﬁrm  this
was  the  case.  Thus,  we  believe  that  our  ﬁndings  indicate
that  the  ADHD  group  --  particularly  those  with  more  severe
inattentive  symptoms  --  manifest  greater  P1  amplitude  for
B--Y  stimuli  than  controls,  but  do  not  differ  in  P1  latency
or  amplitude  for  R--G  stimuli.  This  interpretation  is  further
supported  by  the  speciﬁc  and  positive  correlation  between
the  severity  of  inattention  and  P1  amplitude  for  B--Y
stimuli.
Evidence  of  greater  amplitude  in  P1  in  response  to
blue--yellow  chromatic  stimuli  in  the  adolescents  with  ADHD
suggests  a  greater  involvement  of  their  ventral  extrastriate
cortex  of  the  fusiform  gyrus.20 Based  on  the  various  brain
imaging  and  cellular  level  studies  that  suggest  that  color
perception  and  processing  is  localized  in  the  extrastrate
area,21,22 we  can  assume  that  adolescents  with  ADHD  are
challenged  in  processing  color  information,  hence  require
greater  activation  in  the  area.  The  larger  P1  amplitude  for
blue--yellow  stimuli  might  be  understood  as  a  compensa-
tion  mechanism  for  a  color  deﬁciency  that  ADHD  adolescents
developed  over  time.  In  other  words,  it  might  be  a  way  of
compensating  for  problems  at  the  receptor  level  such  as  rel-
atively  scarce  number  of  short  wavelength  sensitive  cones
and  vulnerability  due  to  low  dopamine.37 Cortical  matura-
tion  in  ADHD  population  is  delayed  compared  to  healthy
children.3
We  acknowledge  the  limitations  of  this  pilot  study,  which
need  to  be  taken  into  account  when  interpreting  the  ﬁnd-
ings.  Sample  sizes  were  small  particularly  for  the  comparison
of  the  two  ADHD  subgroups,  which  limits  the  generaliz-
ability  of  the  ﬁndings  and  necessitates  their  replication  in
larger  samples.  Furthermore,  we  acknowledge  that  high
level  of  inter-subject  variability  in  VEP  measure  has  been
reported,38 and  that  repeatability  of  the  VEP  responses  was
not  tested,  which  weakens  our  ﬁndings  for  P1  amplitude.
However,  a  previous  study  using  the  same  VEP  system  and
method  reported  good  repeatability  of  test  results.33 Also,  in
this  pilot  study,  we  were  not  able  to  disentangle  the  effects
of  medication  and  severity  of  ADHD  symptoms  (according  to
the  SWAN  scores).  Although  we  were  able  to  conﬁrm  which
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articipants  were  being  treated  with  medication,  we  were
nable  to  conﬁrm  whether  they  had  stopped  medication  at
east  24  h  prior  to  the  study  as  requested.  Moreover,  we
cknowledge  that  this  duration  of  washout  may  not  be  suf-
cient  to  eliminate  any  residual  central  (or  retinal)  effects
f  medication.  We  attempted  to  deal  with  the  possible  con-
ound  of  medication  by  comparing  those  who  were  and  were
ot  being  treated  with  medication.  We  believe  that  observed
ifferences  in  the  P1  response  to  B--Y  stimuli  in  the  two  ADHD
roups  may  not  be  attributable  to  the  effects  of  medication,
ecause  it  is  quite  possible  that  those  receiving  medication
iffer  in  a systematic  way  from  those  not  receiving  media-
ion  (i.e.  more  severe  ADHD  symptoms).  Also,  it  is  possible
hat  the  VEP  latency  and  amplitude  measured  in  the  occipi-
al  lobe  may  not  capture  the  impairment  at  a receptor  level
aused  by  hypo-dopaminergic  condition  in  ADHD  group.  For
nstance,  use  of  a  clinical  electroretinogram  technique,  a
ool  to  detect  and  quantify  central  cone  function,  especially
n  disease  stages  with  no  or  subtle  visible  retinal  changes,
ight  be  an  option.  That  approach  would  provide  direct
bservation  of  the  effect  of  low  dopamine  condition  in  the
etina,  particularly  to  blue  and  yellow  cones.
Despite  the  limitations,  we  believe  our  preliminary
ndings  are  provocative  and  provide  a  basis  for  future
nvestigations  on  this  topic.  Future  studies  should  include
ifferent  age  groups  and  more  precise  and  effective  tests
o  assess  neural  and  behavioral  components  of  color  per-
eption,  and  investigate  the  effects  of  attention  on  color
erception  of  B--Y  versus  R--G  chromatic  stimuli.
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Objective  Participants  Method  Results  Conclusions
ranet  et  al.40
(Strabismus)
Determine  any
correlation
between
convergence
insufﬁciency  (CI)
and  ADHD
A  retrospective  review  of  the  266  patients
with  a  diagnosis  of  CI  was  obtained  from
the UCSD  Ratner  Children’s  Eye  Center’s
electronic  database  was  performed
1705  patients  with  a  diagnosis  of  ADHD
were  identiﬁed  from  a  computerized  review
of the  University  of  California,  San  Diego
(UCSD)  Medical  Records’  database
A  computerized  review  was  also  performed
looking  at  the  converse  incidence  of  CI  in
patients  carrying  the  diagnosis  of  ADHD
From  the  266  charts
of patients  with  CI,
26  patients  (9.8%)
had  a  history  of
ADHD.  Of  the  patients
with  ADHD  and  CI,  20
(76.9%)  were  on
medication  for  ADHD
at  the  time  of
diagnosis  for  CI
The  review  of
computer  records
showed  a  15.9%
incidence  (28
patients  out  of  1705)
of  CI  in  the  ADHD
population
ADHD  among
patients  with
CI  is  three-fold
greater
incidence  than
when
compared  with
incidence  of
ADHD  in  the
general  US
population
(1.8--3.3%)
orsting
et al.41
(Optometry)
Evaluate  the
frequency  of  ADHD
behaviors  in
school-aged
children  with
symptomatic
accommodative
dysfunction  or  CI
24  children  aged  8--15
years  (mean  age  10.9
years),  9  boys  and  15
girls,  with
symptomatic
accommodative
dysfunction  and/or  CI
participated
One  parent  of  each
child  completed  the
Connors  Parent
Rating
Scale-Revised  Short
Form  (CPRS-R:S)
On  the  CPRS-R:S,
cognitive
problem/inattention,
hyperactivity,  and
ADHD  index  were
signiﬁcantly  different
from  normative
values
School-aged
children  with
symptomatic
accommodative
dysfunction  or
CI have  a
higher
frequency  of
ADHD-like
behaviors  as
measured  by
the  CPRS-R:S
ouse et  al.42
(Optometry
and  Vision
Science)
Determine  if
children  with
symptomatic  CI
without  the
presence  of
parent-reported
ADHD  have  higher
scores  on  the
academic  behavior
survey
212  children  (mean
age  11.8  years)  with
symptomatic  CI
participated.  The
control  group
consisted  of  49
children  with  normal
binocular  vision  (NBV;
mean  age  12.5  years)
Parents/guardians
of  children  with
symptomatic  CI  or
NBV  completed  the
academic  behavior
survey  (ABS)  and
reported  whether
the  child  had  ADHD
16%  of  the  CI  group
and  6%  of  the  NBV
group  were  classiﬁed
as ADHD  by  parental
report.  Total  ABS
score  for
symptomatic  CI  with
parent  report  of
ADHD  group  was
signiﬁcantly  higher
than  the  symptomatic
CI  with  parent  report
of  no  ADHD  group  and
the  NBV  group
Children  with
CI  with  parent
report  of  no
ADHD  scored
signiﬁcantly
higher  on  the
ABS  when
compared  to
children  with
NBV
arrar et  al.47
(Optometry)
Document  visual
problems  that  may
coexist  with
medicated
children  with
ADHD
Forty-three  children
with  ADHD
participated.  Control
group  consisted  of  43
children  with
matched  for  age  and
gender.  The  ADHD
group  had  previously
A  modiﬁed  College
of  Optometrists  in
Vision  Development
(COVD)  Quality  of
Life  Outcomes
Assessment  was
conducted  by  the
parents  and  children
ADHD  participants
report  and/or
experience  more
symptoms  of  visual
system  dysfunction
than  control  group.
Fourteen  of  the  33
symptoms  were  found
Children  with
ADHD,  under
pharmacologi-
cal  treatment,
report  more
visual  and
quality  of  life
problems  thanbeen  diagnosed  as
ADHD  and  was  under
pharmacological
treatmentto  be  signiﬁcantly
more  severe  in  the
ADHD  group  than  in
the  control  group
control
children
125
ethod  Results  Conclusions
phthalmologic  tests
ere  ﬁrst  performed
ithout  medication:
 Visual  acuity  (VA)
 Strabismus  and  ocular
otility  (heterotropia)
 Stereo  acuity
 Near  point  of
onvergence  (NPC)
 New  point  of
ccommodation
fter  at  least  60  min
hat  children  were
iven  their  regular
timulant  all  tests  were
erformed  in  the  same
rder.  In  addition,  the
ollowing  tests  were
erformed:
 Refraction  under
yclopegia
 Assessment  of  ocular
imensions
 Examination  of
nterior  segment,
edia,  and  ocular
undus
 Photography  of  the
cular  fundus  for
uantitative  digital
age  analysis
 History  taking  of
isual  perception
76%  of  children  with
ADHD  had
ophthalmologic
problems  including
subnormal  VA,
strabismus,  reduced
stereo  vision,
absent  or  subnormal
NPC,  refractive
errors,  small  optic
discs  and/or  signs  of
cognitive  visual
problems
The  children  with
ADHD  had  an
increased
proportion  of
heterophoria  and
poorer  performance
on  visual  acuity  and
convergence  tests
without,  but  not
with,  stimulants
when  compared
with  controls
Children  with
ADHD  had  a
higher
frequency  of
ocular  and
visual
abnormalities
Treatment  with
stimulants
caused  no
signiﬁcant
difference  in
visual  function
They  presented
subtle
morphological
changes  of  the
optic  nerve  and
retinal
vasculature,
indicating  an
early
disturbance  of
the
development  of
neural  and
vascular  tissues
in  the  CNS
oth  groups  underwent
n ophthalmological
xamination  including
est  corrected  distance
isual  acuity  (BCVA),
isual  ﬁeld
xamination,  and
undus  photography
he  ADHD  children  did
ot take  medication  on
he  morning  of  the
itial  examination.
wo  hours  later,  the
hildren  were  given
heir  regular  drug  doses
nd  the  examinations
ere  repeated.  The
ontrol  group  was
Visual  acuity
increased
signiﬁcantly  in  the
ADHD  group  after
treatment.  The
difference  between
the  two  VF
examinations  was
signiﬁcantly  larger
in the  ADHD
compared  with  the
control  group
Signiﬁcantly  more
ADHD  subjects  had
subnormal  VF
results  without
stimulants,
compared  with
Children  with
ADHD  showed
better  VA  and
VF  results  with
than  without
psychostimu-
lant
medicationColor  Vision  in  ADHD-  A  pilot  VEP  study  
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Objective  Participants  M
Grönlund
et  al.43 (Eye)
Investigate  visual
function  and
ocular  features  in
children  with
ADHD  and
establish  whether
treatment  with
stimulants  is
reﬂected  in
functioning  of  the
visual  system
42  children  and
adolescents  with
ADHD  aged  6.3--17.6
years  (mean  age  12
years),  37  boys  and  5
girls,  who  were  being
treated  with
stimulants
participated.
Children  had  been  on
medications  for  a
mean  period  of  19.5
months
The  control  group
consisted  of  50  school
children  (mean  age  of
11.9  years),  44  boys
and  6  girls
O
w
w
-
-
m
-
-
c
-
a
A
t
g
s
p
o
f
p
-
c
-
d
-
a
m
f
-
o
q
im
-
v
Martin et  al.44
(ActaOph-
thalmolog-
ica)
Evaluate  visual
function  in
children  with
ADHD,  and  to
correlate  these
data  with  the
morphology  of  the
optic  nerve,  and
to ﬁnd  out  if  and
how
psychostimulant
medication  affects
visual  functions
18  children  aged  6--17
years  (mean  age  11.9
years),  16  boys  and  2
girls,  diagnosed  with
ADHD  and  treated
with  stimulants
participated.
Children  had  been  on
medication  for  a
mean  period  of  14.7
months.  ADHD
diagnoses  were
determined  according
to DSM-IV  criteria  by
one  physician  in  all
patients
The  control  group
consisted  of  24
B
a
e
b
v
v
e
f
T
n
t
in
T
c
t
a
w
cchildren  aged  7--18
years  (mean  age  11.7
years),  15  boys  and  9
girls
exami
same  
the  ADned  twice,  at  the
time  intervals  as
HD  group
controls,  but  with
stimulants  the
difference  was  no
longer  signiﬁcant
1A
C
A
T26  S.  Kim  et  al.
ppendix  A  (  Continued  )
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hung  et  al.45
(Yonsei
Med  J)
Investigate  the
symptoms  of  ADHD
as reported  by
parents  in  children
with  intermittent
exotropia  [X(T)]
and  to  determine
whether
strabismus  surgery
for  X(T)  affects
ADHD  symptoms
51  children
undergoing  muscle
surgery  for  X(T)  aged
3--9  years  (mean  age
5.96  years),  22  boys
and  29  girls,
participated.  All
patients  had  either
divergence  excess  or
basic  type  X(T)
One  parent  of  each
child  completed  the
ADHD  rating  scale  IV
(ADHD  RS-IV)
assessment,  based  on
the  DSM-IV  home
version,  consecutively
before  and  one  year
after  surgery
(symmetric  lateral
rectus  recession  on
both  eyes)
8  (15.7%)  of  the  51
patients
demonstrated  the
ADHD  trait.  ADHD
RS-IV  scores
following  strabismus
surgery  signiﬁcantly
decreased  in
patients  with  the
ADHD  trait,  while
they  did  not  differ
in patients  without
the  ADHD  trait.  7  of
the  8  patients  with
the ADHD  trait
showed
improvement  in
their  ADHD  RS-IV
scores  after  surgery
The  ADHD  trait
was  relatively
common  in
children  with
X(T),  and  the
parent-
reported
symptoms  of
the  children
with  the  ADHD
trait  improved
after
strabismus
surgery
ppendix B. Literature summary on  color vision in ADHD
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annock  et  al.9
(Journal  of
Abnormal  Child
Psychology)
Investigate  rapid
automatized
naming  (RAN)  and
effects  of
stimulant
medication  in
school-age
children  with
ADHD  with  and
without
concurrent
reading  disorder
(RD)
67  children  with
ADHD,  21  with
ADHD  +  RD,  and  27
healthy
comparison
children
participated.  All
children  were
between  7--12
years  of  age,  80%
of which  were
male
In  a  second  study,
a subgroup  (n  =  47)
of the  total  ADHD
sample
participated  in  an
acute  medication
trial,  35  belonging
to the  ADHD
group,  12  to  the
ADHD  +  RD  group
The  three  groups  were
compared  on:  color
naming  speed,  letter
naming  speed,
phonologic  decoding,
and  arithmetic
computation
In  the  medication  trial,
the  subgroup  of  children
completed  several
academic  and  cognitive
measures  as  well  as
three  of  the  RAN  Tests:
Colors,  Letters,  and
Digits.  Each  child
completed  a
randomized,
placebo-controlled,
cross-over  trial  with
three  single  doses  (10,
15, 20  mg)  of
methylphenidate.  The
active  medication  and
placebo  were
administered  in  a
double-blind  manner
each  morning  during  a
1-week  period.  Testing
under  double-blind
Both  ADHD  groups
were  signiﬁcantly
slower  in  color
naming  than
controls,  but  did
not differ  from
one  another,
showing  evidence
of  an  association
between  deﬁcits
in  color  naming
and  ADHD  that
could  not  be
attributed  to  the
comorbidity  with
RD.
Methylphenidate
selectively
improved
color-naming
speed  but  had  no
effect  on  the
speed  of  naming
letters  or  digits
The  ﬁndings  of
color  naming
impairments  in
ADHD  challenge
the  current
assumption
that  naming
speed  deﬁcits
are  speciﬁc  to
RD  and  also
provide  some
support  for  the
purported
processing
differences
underlying
color  naming
and  letter
naming,  of
which
color-naming
speed  is
improved  by
stimulant
medicationcondi
about
of me
for 2  htions  commenced
 1  h  after  ingestion
dication  and  lasted
127
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rticipants  completed
e Stroop  Color-Word
st  and  Wisconsin  Card
rting  Task  (WCST),
ich  were  selected  as
uropsychological
asures,  as  well  as
te  tasks  in  a
eogame  and  at  the
o,  which  were  used  to
ex  real-life  measures
There  were  no  group
differences  in
executive  function
on  the  Stroop  or  zoo
tasks
The  ADHD  group  was
signiﬁcantly  slower
in color  naming  on
the  Stroop,  and  also
took  more  trials  on
the  WCST  to
complete  sorting
cards  according  to
the  ﬁrst  category  of
color
Color  naming
and  color
processing
deﬁcits  may
exist  in
children  with
ADHD
lor  discrimination
ility  was  investigated
ing  the
rnsworth-Munsell  100
e  Test  (FMT)
ildren  completed  the
oop-
ming  time  and  errors
re  recorded  for  three
btests  separately:
oop-Word,
oop-Color,  and
oop-Color/Word
Children  with  ADHD
committed  more
errors  in
blue--yellow  axis  in
FMT.  They  were  also
slower  in  naming  the
colors  of  stimuli  on
Color-Word
conditions  of  the
Stroop,  but  did  not
differ  in  naming
speed  on  the  Word
condition,  nor  in
Stroop  interference
These  ﬁndings
indicate
problems  in  the
blue--yellow
perception
which  may  be
accounted  by
dopaminergic
mechanisms  in
children  with
ADHD
lor  discrimination
ility  was  investigated
ing  the
rnsworth-Munsell  100
e  Test  (FMT)
rticipants  also
mpleted  the
oop-Color-Word  Task.
ming  time  and  errors
re  recorded  for  three
btests  separately:
oop-Word,
oop-Color,  and
oop-Color/Word.
Color  perception
deﬁcits  were  found
for both  main  factors
(ADHD  and  CTD),  but
there  were  no
interaction  effects
A deﬁcits  on  the
blue--yellow
compared  to  the
red--green  axis  was
detected  for  ADHD
In the  Stroop  task
only  the  ‘pure’  ADHD
group  showed
impairments  in
interference  control
and  other
parameters  of
Stroop  performance
No  signiﬁcant
correlations
Basic  color
perception
deﬁcits  in  both
ADHD  and  CTD
were
suggested,  and
these  deﬁcits
are  additive  in
the  case  of
comorbidity
(ADHD  +  CTD)
The  inﬂuence
of  color
perception
deﬁcits  on
Stroop  task
performance
might  be
negligibleColor  Vision  in  ADHD-  A  pilot  VEP  study  
Appendix  B  (  Continued  )
Objective  Participants  Me
Lawrence  et  al.10
(Journal  of
Attention
Disorders)
Compare
performance  on
both  neuropsy-
chological  and
real-life  measures
of  executive
function  and
processing  speed
44  boys  aged  6--12
years  (mean  age
9.7  years),  22  with
a diagnosis  of
ADHD  and  22
controls
participated
Pa
th
Te
So
wh
ne
me
rou
vid
zo
ind
Banaschewski
et al.6 (Journal
of  Child
Psychology  and
Psychiatry)
Investigate  color
perception  and
performance  on  a
conventional  neu-
ropsychological
task  (Stroop  Task)
that  requires
speeded  naming  of
colored  stimuli  in
children  with
ADHD
27  children  aged
8.0--13.0  years,
consisting  of  14
children  with
ADHD  and  13
controls
participated
Co
ab
us
Fa
Hu
Ch
Str
Na
we
su
Str
Str
Str
Roessner et  al.7
(J  Neural
Transm)
Examine  color
perception  in
ADHD  and  Chronic
Tic  Disorders
(CTD)  to  clarify
which  factor
(ADHD  versus  CTD)
inﬂuences  color
vision  parameters
especially  in  the
case  of  the
comorbidity  of
ADHD  +  CTD
69  children  aged
8.0--12.6  years,  14
with  a  diagnosis  of
ADHD,  22  with
CTD,  19  with
ADHD  +  CTD,  14
healthy  controls
Co
ab
us
Fa
Hu
Pa
co
Str
Na
we
su
Str
Str
StrColor-Word  Task. both  the  Color  and retinalbetween  any  FMT
variable  and  color
naming  in  the  Stroop
task were  found
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een  c
cond
jects
ing  b
lors.
d  con
ided
d  pla
d--gre
llow-
e  sp
ch  ta
s  me
K rticip
ual  A
estio
rform
rnsw
e  tes
ick  T
eed  (
A
e
[
M
D
R
D
B
D
F
F
D
D
F
F
D
D
D
F
[
D
F
F
F
F
F
D
B
D
F
D28  
ppendix  B  (  Continued  )
Objective  Participants  Me
ilva  and  Frère8
(Biomedical
Engineering
Online)
Examine
blue--yellow  color
discrimination  in
ADHD  individuals
using  a  virtual
environment  that
is  capable  of
quantifying  the
inﬂuence  of
red--green  versus
blue--yellow  color
stimuli  on
participant
performance
20  ADHD  and  20
control  matched
for  age  and  gender
participated
(15--25  years,  17
men  and  23
women)
An
ga
re
th
mu
hin
dif
on
inf
pa
gr
se
ob
us
co
an
div
an
re
ye
tim
ea
wa
im et  al.5
(Journal  of
Optometry)
Evaluate  color
vision  deﬁciency  in
adults  with  ADHD
and  the  impact  of
everyday  life
30  adults  with
ADHD  and  30
controls  matched
for  age  and  gender
Pa
Vis
Qu
pe
Fa
Hu
Qu
Sp
ppendix C. Comments on fundus exam for
ach  individuals in ADHD and control group
ADHD,  N  =  16]
edia  clear,  disk  natural,  macula  well  developed
isk  Normal,  Macula  Normal
E-Myopic  crescent  at  disk  --  rest;  LE  within  normal  limits
isk and  vessels  normal,  macular  reﬂex  --  well  developed
oth eyes  optic  disk  normal,  vessels  normal,  macular  reﬂex
well  developed
isk  normal  and  macula  normal
undus  within  normal  limits
undus  natural
isk  normal;  macula  normal
isk  normal;  macular  reﬂex  normal
undus  normal  both  eyes
undus  BE  Norms
isk  and  macula  normal  both  eyes
isk and  macula  normal
D
D
F
FS.  Kim  et  al.
 Results  Conclusions
ractive  computer
ased  on  virtual
was  used.  Within
e,  the  player
nd  and  interpret
attered  in
nt  scenarios.  In
sion,  hints  and
tion  boards  were
 using  red  and
olors.  In  the
 version,  these
 were  painted
lue  and  yellow
 The  ADHD  group
trol  group  were
 into  subgroups
yed  either  the
en  version  or  the
-blue  version.  The
ent  to  complete
sk  of  the  game
asured
Use  of  blue/yellow
instead  of  green/red
colors  decreased  the
game  performance
of  all  participants.
However,  a  greater
decrease  in
performance  was
observed  with
participants  with
ADHD
Color
inﬂuences  the
performance  of
executive  tasks
that  require
attention.
ADHD
participants
were  more
inﬂuenced  by
blue--yellow
than  control
group
ants  completed
ctivities
nnaire  (VAQ)  and
ed
orth-Munsell  100
t  (FMT)  and  A
est  of  Cognitive
AQT)
Adults  with  ADHD
reported  more  visual
activities  problems
on  VAQ.  They  also
committed  more
errors  in  FMT,
particularly  in  Blue
spectrum
Color  vision
problem,
particularly  in
blue  spectrum
is  replicated  in
adult  with
ADHD.  A
comprehensive
research  on
mechanism
underlying
color  vision
deﬁcit  is
warranted
isk  normal  both  eyes,  Macula  normal  both  eyes
undus  normal  both  eyes
Control,  N  =  15]
isk  and  macula  normal
undus  normal  both  eyes
undus  --  tilted  disk  both  eyes;  Macular  reﬂex  positive
undus  normal  both  eyes
undus  --  No  abnormality  detected  both  eyes;  CL  prescription
R.E.: −4.5,  L.E.  −5
undus  both  eyes  normal
isk  and  vessels  normal.  Macular  reﬂex  well  developed
E --  disk,  vessels  and  macula  normal
isk,  macula,  vessels  normal
undus  OK
isk,  vessels,  and  macula  normal
isk,  macula,  vessels  normal
isk,  macula,  vessels  normal  both  eyes
undus  (disk,  vessels,  and  macula)  normal
undus  (Disk,  Macula,  Vessels)  Normal
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